tert-butylhydroperoxide has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blegniski, FP; da Silva Zanoni, KP; de Souza, SRG; Fracaro, L; Guarnier, FA; Martins, HA; Silva, TNX; Vicentini, GE; Zanoni, JN | 1 |
| Castilho, RF; Degasperi, GR; Vercesi, AE | 1 |
2 other study(ies) available for tert-butylhydroperoxide and Carcinoma 256, Walker
| Article | Year |
|---|---|
Does l-glutamine-supplemented diet extenuate NO-mediated damage on myenteric plexus of Walker 256 tumor-bearing rats?
Topics: Animals; Antioxidants; Cachexia; Carcinoma 256, Walker; Dietary Supplements; Disease Models, Animal; Glutamine; Ileum; Jejunum; Male; Myenteric Plexus; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Oxidative Stress; Rats; Rats, Wistar; tert-Butylhydroperoxide; Tumor Burden | 2017 |
High susceptibility of activated lymphocytes to oxidative stress-induced cell death.
Topics: Animals; Apoptosis; Calcium; Carcinoma 256, Walker; Chelating Agents; Deferoxamine; Egtazic Acid; Flow Cytometry; Lymphocyte Activation; Lymphocytes; Male; Membrane Potentials; Mitochondria; Nifedipine; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Siderophores; Spleen; tert-Butylhydroperoxide; Time Factors | 2008 |